Nasal PT-141
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
Pre-formulated PT-141 (bremelanotide) research solution examined in MC3R-, MC4R-, and route-specific material models.
Mix and match any items — discount applies automatically at checkout.
Earn 54 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for controlled laboratory receptor and pathway research.
What is Nasal PT-141?
Nasal PT-141 is the pre-formulated research-solution format of bremelanotide, a synthetic cyclic heptapeptide melanocortin receptor agonist.
Laboratory research examines MC3R- and MC4R-associated signalling, receptor selectivity, ligand-response relationships, and route-specific material characteristics.
The lyophilized research format is listed separately as PT-141 (Bremelanotide) vials.
Nasal PT-141 verification and batch lookup
No nasal-format-specific analytical report is currently represented as being on file. Each unit carries a batch identifier researchers can search through the public lookup. The transparency page explains the general verification framework without presenting it as a result for a specific nasal batch.
Nasal PT-141 research material specifications
| Compound | PT-141 (bremelanotide) |
|---|---|
| Class | Synthetic cyclic heptapeptide melanocortin receptor agonist |
| Format | Pre-formulated nasal research solution |
| Concentration | 10 mg/ml |
| Fill volume | 15 ml spray bottle |
| Purity specification | ≥99% |
| Testing | Batch documentation available through the public lookup when released; no nasal-format-specific report represented as on file |
| Storage | Refrigerated, upright, and protected from light; follow batch documentation |
| Origin | Shipped domestically from the USA with tracked delivery |
Nasal PT-141 research questions
+What is Nasal PT-141?
Nasal PT-141 is a pre-formulated research-solution format of the synthetic melanocortin receptor agonist bremelanotide.
+How is the nasal format different from PT-141 vials?
The nasal listing is a pre-formulated solution, while the vial listing contains sealed lyophilized material. They have separate formats, handling requirements, and batch documentation.
+Which pathways are relevant to Nasal PT-141 research?
Laboratory literature examines melanocortin receptor binding and downstream MC3R- and MC4R-associated signalling measurements.
+Is a nasal-format-specific PT-141 report on file?
No nasal-format-specific analytical report is currently represented as being on file. Use the public batch lookup to see which documentation is available for a specific unit.
+What concentration and format are supplied?
Nasal PT-141 is supplied as a 15 ml research solution at 10 mg/ml. Current pricing and availability appear on this page.
+How should Nasal PT-141 research material be stored?
Keep the sealed bottle refrigerated, upright, protected from light, and within the conditions stated in its batch documentation.
Read the Nasal PT-141 research
A laboratory-focused overview of PT-141 (bremelanotide), its cyclic heptapeptide structure, melanocortin receptor profile, MC3R and MC4R signaling, analytical verification, and research limitations.
Read article →A receptor-level review of PT-141 (bremelanotide), emphasizing MC3R and MC4R agonism, melanocortin receptor selectivity, assay endpoints, and experimental limitations.
Read article →Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.